NCT07181720 2025-10-02CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid TumorsChongqing Precision Biotech Co., LtdPhase 1 Recruiting90 enrolled
NCT04418167 2025-09-03JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway MutationsJS InnoPharm, LLCPhase 1 Suspended71 enrolled
NCT04579757 2025-05-08Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid TumorsHutchmedPhase 1/2 Terminated87 enrolled 29 charts
NCT02404441 2022-08-03Phase I/II Study of PDR001 in Patients With Advanced MalignanciesNovartisPhase 1/2 Completed319 enrolled 41 charts
NCT02012231 2020-10-19Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.Fore BiotherapeuticsPhase 1 Terminated5 enrolled